- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
11:41pm
9:13pm
Royalty makes bid to take over Elan
Private equity group in move to gain access to drug income
5:15pm
Reckitt Benckiser hit by generic ruling
Rival versions of highly profitable Suboxone get green light
From
FINANCIALS
10:50pm
Ireland ripe for M&A surge, says report
Potential deals highlighted in pharmaceutical and medical sectors
From
LEX
8:09pm
Reckitt Benckiser: motorcycle maintenance
The pharma side is proving a creaky sidecar
Feb 25, 2013
Genus plans further China expansion
Animal genetics group eyes joint ventures in pork farming
From
LEX
Feb 25, 2013
Elan / Royalty Pharma: gone shopping
Which investment banker-turned-pharma executive will investors choose to back?
©Reuters
Feb 24, 2013
Novartis’ U-turn marks a crossroads
Retirement package for Vasella raises investor scrutiny over pay
Feb 23, 2013
Elan unveils share $1bn buyback
Drug group’s plan includes move to seek fresh acquisitions
From
MARKETS
Feb 23, 2013
Phytopharm falls after drug test failure
Trial for Parkinson’s treatment shows drug has no effects
Feb 22, 2013
Vasella admits mistakes over $78m payout
Shareholders not appeased by Novartis chairman’s concession
From
WORLD
Feb 20, 2013
Pryce faces retrial after jury discharged
Circumstances of case raise questions about jury system
From
TECHNOLOGY
Feb 20, 2013
Winners of life science prize revealed
Silicon Valley billionaires pledge $50m
Feb 19, 2013
Novartis pay criticism unlikely to abate
The group is still likely to face an uncomfortable grilling, write James Shotter and Andrew Jack
Feb 18, 2013
Novartis chairman’s pay-off sparks anger
Vasella to be given SFr72m ‘golden goodbye’ for confidentiality
From
WORLD
Feb 18, 2013
Suffering side-effects of health reform
Critics see threat to Obamacare goals
Multimedia
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey
*FT has grown in every major readership survey MOST POPULAR NOW ON FT.COM
COMPANIES NEWS ON TWITTER
More FT Twitter accounts
EDITOR’S CHOICE
-
Chief Executive, Shareholder Executive
BIS
-
VP EUROPEAN SALES
Manufacturing
-
Senior Analyst, NA Gas Infrastructure Pipeline
Wood Mackenzie
-
Chief Financial Officer
Marine Transportation Industry
TOOLS & SERVICES
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- Newslines
- Today's newspaper
- FT press cuttings
- FT ebooks
- FT ePaper
- Economic calendar
Return of bear hug would show M&A revival
Royalty Pharma’s bid for Elan is well below a killer price